Clinical Research Drug Trials Treatment 
Advarra
JUNE 27, 2023
Each phase has a different purpose in testing the treatment’s safety and efficacy. This article explores how the clinical research phases protect study volunteers from harm and ensure new drugs and therapies are developed effectively. Therefore, clinical research is a fundamental aspect of medical advancement.
Drug Discovery World
JUNE 9, 2023
Novel glycan-coated nanoparticle enters trials for geographic atrophy Aviceda Therapeutics has dosed the first patient in its Phase II SIGLEC trial investigating AVD-104 as a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
FEBRUARY 10, 2023
Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient populations in trials were exposed.
Drug Discovery World
FEBRUARY 20, 2023
Capivasertib could offer a completely new treatment option for these patients. This is great news for men, and we hope that this temporary approval leads to the treatment being rolled out permanently across the UK.” 4. The data showed a complete response in all 14 patients who received dostarlimab as a first-line treatment.
Conversations in Drug Development Trends
NOVEMBER 3, 2022
BioPharma Dive interviewed our Derek Ansel on how to conduct psychedelic clinical research. In April 2022, the Food and Drug Administration (FDA) issued draft guidance on developing a “Race and Ethnicity Diversity Plan” for clinical trials. Looking to diversify the reach of your orphan drug trial?
PPD
MARCH 28, 2024
With fierce competition for available capital and resources, investors expect a clear demonstration of return on investment (ROI) — a factor on prominent display in industry research conducted by the PPD clinical research business of Thermo Fisher Scientific.
The Pharma Data
NOVEMBER 10, 2020
This is encouraging as a pharmacodynamic biomarker in larger trials,” Dage said. The assay is being explored for applications in clinical research, including new drug trials, based on its capability to identify patients with Alzheimer’s disease and also to predict their risk of progression.
Expert insights. Personalized for you.
52 
Let's personalize your content